Clinical trials
Follow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Company intelligence / Profile preview
Ningxia Taiyicin Biotech
银川市（Yinchuan City）, 贺兰县暖泉工业园区（Helan County Nuanquan Industrial Park）, 宁夏回族自治区（Ningxia Hui Autonomous Region）, 中国（China）taiyixin-bio.com ↗
- Ownership
- Private
- Development stage
- Other
01
Overview
Ningxia Taiyicin Biotech is a large-scale Chinese pharmaceutical company specializing in the research, development, production, and sales of active pharmaceutical ingredients (APIs), especially antibiotics such as erythromycin thiocyanate, lincomycin hydrochloride, azithromycin dihydrate, clarithromycin, tylosin tartrate. The company holds GMP certification from China’s agriculture administration and international quality certifications including CEP and USFDA for several products. Its products are sold to over 120 countries.
- Therapeutic areas
- Infectious Diseases
- Modalities
- Small moleculeAntibioticPeptides
- Industry
- Chemicals & Materials
Beyond the preview
Go deeper on Ningxia Taiyicin Biotech.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Licensing & deals
Explore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Trace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Compare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Explore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Connect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on Ningxia Taiyicin Biotech.